Prospective comparison of recurrence score and inde-pendent central pathology assessment of prognostic tools in early breast cancer (BC): Focus on HER2, ER, PR, Ki-67 results from the phase III WSG-Plan B trial - Gluz, O; Kreipe, H H; Christgen, M (J Clin Oncol, 2012)
et al.